Oculus Innovative Sciences to Participate in Third Congress of the World Union of Wound Healing Societies in Toronto May 15, 2008
Oculus Innovative Sciences Announces Initial Chinese Commercialization Plan for Launch of Microcyn(R) Technology May 5, 2008
Oculus Innovative Sciences Appoints Michelle Carpenter, JD, RAC, as Vice President of Regulatory Affairs and Quality Apr 23, 2008
Oculus Innovative Sciences' CEO and Founder Hoji Alimi Featured on NASDAQ CEO Signature Series Apr 17, 2008
Oculus Innovative Sciences Announces Publication of Microcyn(R) Technology Diabetic Wound Study in Journal of College of Physicians and Surgeons Pakistan Apr 15, 2008
Oculus Innovative Sciences Receives Chinese SFDA Regulatory Approval of Microcyn(R) Technology Mar 27, 2008
Oculus Innovative Sciences Announces Positive Results From Three Abstracts Evaluating the Use of Microcyn(R) Technology in Diabetic Foot Ulcers Mar 17, 2008
Oculus Innovative Sciences Announces Additional Phase II Data for Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers Mar 14, 2008
Oculus Innovative Sciences Announces Acceptance of Three Abstracts on the use of Microcyn(R) Technology in Diabetic Foot Ulcers by DFCon 08 Mar 12, 2008
